These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3539898)

  • 1. An outcome study of the RTOG Cancer Control program.
    Gillespie BW; Diamond JJ; Davis LW; Rominger CJ
    Int J Radiat Oncol Biol Phys; 1986 Dec; 12(12):2157-63. PubMed ID: 3539898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Participation of community hospitals in clinical trials: analysis of five years of experience in the Eastern Cooperative Oncology Group.
    Begg CB; Carbone PP; Elson PJ; Zelen M
    N Engl J Med; 1982 May; 306(18):1076-80. PubMed ID: 7070403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes research in cancer clinical trial cooperative groups: the RTOG model.
    Bruner DW; Movsas B; Konski A; Roach M; Bondy M; Scarintino C; Scott C; Curran W
    Qual Life Res; 2004 Aug; 13(6):1025-41. PubMed ID: 15287270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the Radiation Therapy Oncology Group and American Joint Committee on Cancer staging systems among patients with non-small cell lung cancer receiving hyperfractionated radiation therapy. A report of the Radiation Therapy Oncology Group protocol 83-11.
    Curran WJ; Cox JD; Azarnia N; Byhardt RW; Shin KH; Emani B; Phillips TL; Selim H; Herskovic A; Mohiuddin M
    Cancer; 1991 Aug; 68(3):509-16. PubMed ID: 1648432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation Therapy Oncology Group (RTOG) studies in head and neck cancer.
    Marcial VA; Pajak TF; Kramer S; Davis LW; Stetz J; Laramore GE; Jacobs JR; Al-Sarraf M; Brady LW
    Semin Oncol; 1988 Feb; 15(1):39-60. PubMed ID: 3278390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: a retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group trials (RTOG) for glioblastoma multiforme and anaplastic astrocytoma.
    Prados MD; Scott CB; Rotman M; Rubin P; Murray K; Sause W; Asbell S; Comis R; Curran W; Nelson J; Davis RL; Levin VA; Lamborn K; Phillips TL
    Int J Radiat Oncol Biol Phys; 1998 Feb; 40(3):653-9. PubMed ID: 9486616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evolution of Radiation Therapy Oncology Group (RTOG) protocols for nonsmall cell lung cancer.
    Byhardt RW
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1513-25. PubMed ID: 7635796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
    Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
    J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assuring access to state-of-the-art care for U.S. minority populations: the first 2 years of the Minority-Based Community Clinical Oncology Program.
    Kaluzny A; Brawley O; Garson-Angert D; Shaw J; Godley P; Warnecke R; Ford L
    J Natl Cancer Inst; 1993 Dec; 85(23):1945-50. PubMed ID: 8230286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Radiation Therapy Oncology Group: a progress report.
    Davis LW; Gelber R; Kramer S; Zelen M; Rubin P
    Cancer Clin Trials; 1978; 1(2):83-8. PubMed ID: 391426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Radiotherapy combined with hormonal therapy as treatment method in patients with prostate cancer: still more questions than answers].
    Milecki P
    Przegl Lek; 2005; 62(12):1455-9. PubMed ID: 16786772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperative groups and community hospitals. Measurement of impact in the community hospitals.
    Begg CB; Zelen M; Carbone PP; McFadden ET; Brodovsky H; Engstrom P; Hatfield A; Ingle J; Schwartz B; Stolbach L
    Cancer; 1983 Nov; 52(9):1760-7. PubMed ID: 6616426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Creating a "culture of research" in a community hospital: Strategies and tools from the National Cancer Institute Community Cancer Centers Program.
    Dimond EP; St Germain D; Nacpil LM; Zaren HA; Swanson SM; Minnick C; Carrigan A; Denicoff AM; Igo KE; Acoba JD; Gonzalez MM; McCaskill-Stevens W
    Clin Trials; 2015 Jun; 12(3):246-56. PubMed ID: 25691600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of stage I lung cancer in high-risk and inoperable patients: comparison of prospective clinical trials using stereotactic body radiotherapy (RTOG 0236), sublobar resection (ACOSOG Z4032), and radiofrequency ablation (ACOSOG Z4033).
    Crabtree T; Puri V; Timmerman R; Fernando H; Bradley J; Decker PA; Paulus R; Putnum JB; Dupuy DE; Meyers B
    J Thorac Cardiovasc Surg; 2013 Mar; 145(3):692-9. PubMed ID: 23174176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of a sampling review process for radiation oncology quality assurance in cooperative group clinical trials--results of the Radiation Therapy Oncology Group (RTOG) analysis.
    Martin LA; Krall JM; Curran WJ; Leibel SA; Cox JD
    Radiother Oncol; 1995 Jul; 36(1):9-14. PubMed ID: 8525028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Globalization of the Radiation Therapy Oncology Group: implementation of a model for service expansion and public health improvement.
    Corn BW; Wexler ID; Suntharalingam M; Inbar M; Curran WJ;
    J Clin Oncol; 2008 Mar; 26(7):1160-6. PubMed ID: 18309952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose escalation in chemoradiation for anal cancer: preliminary results of RTOG 92-08.
    John M; Pajak T; Flam M; Hoffman J; Markoe A; Wolkov H; Paris K
    Cancer J Sci Am; 1996; 2(4):205-11. PubMed ID: 9166533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technical Note: Dosimetric evaluation of Monte Carlo algorithm in iPlan for stereotactic ablative body radiotherapy (SABR) for lung cancer patients using RTOG 0813 parameters.
    Pokhrel D; Badkul R; Jiang H; Kumar P; Wang F
    J Appl Clin Med Phys; 2015 Jan; 16(1):5058. PubMed ID: 25679161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution and accomplishments of the Radiation Therapy Oncology Group.
    Cox JD
    Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):747-54. PubMed ID: 7558966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of institutional experience on survival outcome of patients undergoing combined chemoradiation therapy for inoperable non-small-cell lung cancer.
    Lee JS; Scott CB; Komaki R; Ettinger DS; Sause WT
    Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):362-70. PubMed ID: 11872281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.